387018000: Entacapone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Substance with methyltransferase inhibitor mechanism of action (substance)\Substance with catechol-O-methyltransferase inhibitor mechanism of action (substance)\Entacapone (substance)

\Drug or medicament (substance)\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\Substance with catechol-O-methyltransferase inhibitor mechanism of action (substance)\Entacapone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Nitrile\Entacapone (substance)

\Organic compound\Organic cyclic compound\Substance with phenol structure\Catechol\Entacapone (substance)
\Organic compound\Organic nitrogen compound\Nitrile\Entacapone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Entacapone (substance)	Is a	Substance with catechol-O-methyltransferase inhibitor mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Entacapone (substance)	Has disposition	Catechol-O-methyltransferase inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Entacapone (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Entacapone (substance)	Is a	Nitrile	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Entacapone (substance)	Is a	Catechol	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing entacapone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Entacapone 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa+levodopa+entacapone	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has basis of strength substance (attribute)	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Entacapone 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Entacapone 200 mg oral tablet	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has basis of strength substance (attribute)	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has precise active ingredient	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Entacapone 200 mg oral tablet	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing entacapone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only carbidopa and entacapone and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only entacapone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only entacapone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Entacapone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461196010	Entacapone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481132017	Entacapone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461196010	Entacapone (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461196010	Entacapone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481132017	Entacapone	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481132017	Entacapone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49551000195113	entacapone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63721000195116	Entacapon	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
808661000172119	entacapone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
808661000172119	entacapone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
49551000195113	entacapone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63721000195116	Entacapon	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module